Osteopenia Suspended Phase 2 Trials for Alendronic acid (DB00630)

Also known as: Osteopaenia / Bone loss

IndicationStatusPhase
DBCOND0015922 (Osteopenia)Suspended2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01460654Testosterone and Alendronate in Hypogonadal MenTreatment